MediWound: companies and medicines worldwide

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
NexoBrid	Bromelains	EU (EMA)	Authorised	2012
NEXOBRID8.8% · GEL	Anacaulase	United States	Marketed	2022
NEXOBRIDGel	Bromelains	Italy	Authorised
NEXOBRID 2 g polvo y gel para gel2 g · Polvo y gel para gel	Concentrado enzimas proteoliticas enriquecidas en bromelaina	Spain	Authorised	2014
NexoBrid 5 g poeder en gel voor gelGel	Bromelains	Netherlands	Authorised	2012
NEXOBRID 5 g polvo y gel para gel5 g · Polvo y gel para gel	Concentrado enzimas proteoliticas enriquecidas en bromelaina	Spain	Marketed	2014
NEXOBRID 5g5 g · Pulb. + gel pt. gel	Bromelains	Romania	unknown

Medicine	Substance	Country	Status	Authorised
NexoBrid	Bromelains	EU (EMA)	Authorised	2012
NEXOBRID8.8% · GEL	Anacaulase	United States	Marketed	2022
NEXOBRIDGel	Bromelains	Italy	Authorised
NEXOBRID 2 g polvo y gel para gel2 g · Polvo y gel para gel	Concentrado enzimas proteoliticas enriquecidas en bromelaina	Spain	Authorised	2014
NexoBrid 5 g poeder en gel voor gelGel	Bromelains	Netherlands	Authorised	2012
NEXOBRID 5 g polvo y gel para gel5 g · Polvo y gel para gel	Concentrado enzimas proteoliticas enriquecidas en bromelaina	Spain	Marketed	2014
NEXOBRID 5g5 g · Pulb. + gel pt. gel	Bromelains	Romania	unknown

Country	Medicines	Current	Past	Companies
Spain	2	2	0	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines
Italy	1	1	0	Companies All medicines
Netherlands	1	1	0	Companies All medicines
Romania	1	0	1	Companies All medicines
United States	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 10 sources

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removalCorrections from the company itself are welcome.

MediWound

Group structure

Germany1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

MediWound

Group structure

Germany1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇩🇪Germany1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇩🇪Germany1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Germany1

Germany1